These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 371652)

  • 1. The influence of combined treatment with propranolol and acetylsalicylic acid on platelet aggregation in coronary heart disease.
    Keber I; Jerse M; Keber D; Stegnar M
    Br J Clin Pharmacol; 1979 Mar; 7(3):287-91. PubMed ID: 371652
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in platelet aggregation in coronary sinus and aortic blood in patients with coronary artery disease: effect of propranolol.
    Mehta J; Mehta P; Pepine CJ
    Clin Cardiol; 1978 Aug; 1(2):96-100. PubMed ID: 756822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100).
    Feuring M; Haseroth K; Janson CP; Falkenstein E; Schmidt BM; Wehling M
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):584-8. PubMed ID: 10599950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-platelet aggregation action and paradoxical effects of acetylsalicylic acid].
    Mocchi N; Sbalzarini G; Cantaluppi P
    Clin Ter; 1985 Jul; 114(1):37-41. PubMed ID: 4042578
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of dopamine on human platelet aggregation, in vitro.
    Braunstein KM; Sarji KE; Kleinfelder J; Schraibman HB; Colwell JA; Eurenius K
    J Pharmacol Exp Ther; 1977 Feb; 200(2):449-57. PubMed ID: 839449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different patterns of inhibition of adrenaline-induced platelet aggregation and kinetics in vivo by acetylsalicylic acid and indobufen.
    Fortunato JS; Pinheiro MJ; Monteiro MC; Rodrigues MA; Amaral I
    J Int Med Res; 1991; 19(4):305-17. PubMed ID: 1916004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
    Caruzzo C; Belli R; Biasci R; Gaschino G; Bruna C
    Minerva Cardioangiol; 1979 Jun; 27(6):367-72. PubMed ID: 38413
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of aspirin and propranolol alone and in combination on hemostatic determinants in the healthy cat.
    Allen DG; Johnstone IB; Crane S
    Am J Vet Res; 1985 Mar; 46(3):660-3. PubMed ID: 3994130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet aggregation studies in coronary artery disease. Past 4. Effect of aspirin.
    Mehta J; Mehta P; Burger C; Pepine CJ
    Atherosclerosis; 1978 Oct; 31(2):169-75. PubMed ID: 728235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aspirin and propranolol on feline platelet aggregation.
    Greene CE
    Am J Vet Res; 1985 Sep; 46(9):1820-3. PubMed ID: 3931514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of propranolol and aspirin in decreasing platelet aggregation in occlusive cerebrovascular diseases.
    Gupta MC; Dhamija JP; Mathur DS; Sharma BM
    J Assoc Physicians India; 1983 Sep; 31(9):565-7. PubMed ID: 6668264
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of low-dose acetylsalicylic acid on thrombocytes in health subjects and in patients with coronary heart disease].
    Terres W; Schuster O; Kupper W; Bleifeld W
    Dtsch Med Wochenschr; 1989 Aug; 114(33):1231-6. PubMed ID: 2504574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of low-dose aspirin on platelet aggregation and the biosynthesis of PGI2 and TXA2 in patients with coronary heart disease].
    Gao SW; Chen ZJ; Tao SQ
    Zhonghua Nei Ke Za Zhi; 1987 Apr; 26(4):209-12, 255. PubMed ID: 3308356
    [No Abstract]   [Full Text] [Related]  

  • 15. [Potential utility of optic aggregometry for identification of patients with coronary heart disease resistant to acetylsalicylic acid].
    Puchin'ian NF; Furman NV; Dovgalevskiĭ IaP
    Klin Med (Mosk); 2013; 91(1):37-41. PubMed ID: 23659069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha- and beta-adrenergic antagonist on epinephrine-induced aggregation and intracellular free calcium concentration in human platelets.
    Kimura Y; Okuda H
    Biochem Biophys Res Commun; 1994 Jul; 202(2):1069-75. PubMed ID: 7914077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood platelet function in patients with coronary disease after administration of acetylsalicylic acid and dipyridamole].
    Olszańska-Skorek T; Mazurowa A; Pełczyńska I; Chojnowski K; Hołub A; Drzewoski J
    Pol Tyg Lek; 1983 Feb; 38(9):269-72. PubMed ID: 6866846
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood serum salicylate concentration and platelet aggregation after administration of acetylsalicylic acid].
    Mazurowa A; Olszańska-Skorek T; Chojnowski K; Pełczyńska I; Skretkowicz J; Szumejko E; Eichelkraut A
    Pol Arch Med Wewn; 1980 Dec; 64(6):497-504. PubMed ID: 7208366
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of tongxinluo capsule on platelet aggregation function in patients with aspirin resistance].
    Yin CH; Bi DP; Du M
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Apr; 30(4):380-2. PubMed ID: 20669674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.